Compound: Cabozantinib

Drug Target: VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL

Drug Target pathway: RTK signaling

Dataset


Tissue specific analysis

Statistics

All cell lines
Number of cell lines
Pearson correlation
Spearman correlation

Chart settings

Colour dots by:


Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.